Dr. Mukund Seshadri will present their interdisciplinary research on developing and evaluating ultrasound and photoacoustic imaging for oral oncology applications, with a focus on the prognostic utility of these methods in assessing treatment responses in head and neck cancer patients.
Chemotherapy treatment is incredibly difficult on patient wellbeing, but an unlikely plant-derived substance may yet improve the adverse side effects. In this blog, we discuss the use of CBD as a treatment for side effects like organ damage and drug resistance in cancer patients receiving chemotherapy.
Ellie Siebeneck is one of 10 winners of the inaugural Scientist.com STEM Research NIL Award. In this episode, she discusses her passion for learning, mentorship and where the road lies ahead for her academic journey.
The combination of anti-cancer drugs, or combination therapy, has been hailed as a “cornerstone of cancer therapy” since it targets key pathways synergistically, thereby enhancing efficacy compared to monotherapies. This blog takes a look at a recent publication in Nature, which reported the effects of 2025 pairwise drug combinations in breast, colon, and pancreatic cell lines.
Join Dr. Danyi Wen as she describes a novel drug efficacy test using Patient Derived Xenograft (PDX) samples to measure drug efficacy and identify therapeutic candidates in personalized oncology treatments.
Grace Walton, Jonathan Nakashima, and Meghan Loy kick off Episode 1 of Scientist.com's Cutting Edge Conversations series with a presentation on fundamentals and future trends around the role of in vivo studies in personalized medicine
Dr. Marcela Maus discusses CAR T Cell research, the components and technologies used in making a T cell product, important considerations for efficacy, and underlying mechanisms of toxicity and resistance.